In the News
Rheumatoid Arthritis News- November 29, 2016
Genalyte recently presented promising data on its new Maverick Detection System, demonstrating its potential to be used in a near patient setting to improve turnaround time for test results and diagnosis for several conditions, including rheumatoid arthritis (RA).
San Diego Business Journal- November 23, 2016
Genalyte Inc. has landed $36 million in funding to accelerate the development of its blood-testing technology.
GenomeWeb- November 21, 2016
San Diego-based Genalyte will use the funds to further refine its Maverick Detection System, a photonic microring sensor-based platform that the company is developing for rapid blood testing in outpatient settings like doctors’ offices.
TechCrunch- November 21, 2016
Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group.
Business Insider- November 20, 2016
On Sunday, Genalyte, a company that’s developing tests that run on a drop of blood, raised a $36 million round of funding from Khosla Ventures and Redmile Group.
BloombergA – March 7,A 2016
Cary Gunn CEO/Founder Genalyte Inc Discussing providing rapid diagnostic testing right in the doctora s office from a single drop of blood.
Tech InsiderA -A FebruaryA 10,A 2016
Theranos is under a lot of heat these days. But even if the controversial biotech startupA fails, it was right about one major thing: the blood testing experience is ripe for disruption.
Genalyte is taking the single fingertip blood test to the next level (yet another Theranos competitor)
Medcity NewsA – January 8,A 2016
The hype about a single fingertip-prick blood test has clearly become mainstream at this point, especially considering Theranosa somewhat unfortunate publicity. But some companies, Genalyte for example, are taking a similar approach a more closely in comparison than some others.
The HillA -A November 10,A 2015
As the CEO of an emerging diagnostics company, I speak with patients and doctors on a regular basis, and am struck by how poorly the industry is serving their needs. The current patient experience is miserable.
Genome WebA – August 21,A 2015
Having recently closed a $44 million Series C financing round, biotech firm Genalyte aims to use the funds to develop its Maverick biosensor system for rapid, routine testing in doctors’ office.
The San Diego Union-TribuneA – August 18,A 2015
Genalyte, a San Diego biomedical company, said Tuesday it has raised $44 million from venture capital firms. The money will help Genalyte commercialize its diagnostics system, which produces test results in minutes from one drop of blood…
Genome WebA – August 18,A 2015
San Diego-based diagnostics firm Genalyte today announced it has completed a $44M Series C financing round.A Khosla Ventures joined previous investors Redmile Group, Claremont Creek Ventures, and BioMed Ventures in the round…
Fierce Medical Devices – August 18,A 2015
Move over Theranos, here comes Genalyte. The former has made a big splash in the last year as it works to make diagnostics that are cheaper, require only a drop of blood and directly available to consumers…
Genome Web – February 3,A 2015
Since the grant was awarded and the project began in fall of 2013,A GenalyteA has developed an initial panel of 39 of the most promising TAAsA …
Genome Web – January 20,A 2015
Now, though,A GenalyteA has developed a test that it says can tell whether a patient has Ebola or one of a number of other similar diseases…
BBC World Services – November 7, 2014
Time is of the essence when it comes to fighting the Ebola virus…
The Wall Street Journal – November 5, 2014
The New York Times – November 5, 2015
San Diego 6 – October 29, 2014
WHLT – October 28, 2014
Fox 5 San Diego – October 27, 2014
Yahoo Finance – October 27, 2014
Fox News – October 27, 2014
CBS 8 – October 24, 2014
UT San Diego – October 22, 2014
The Hill – October 21, 2014
CQ Healthbeat News – October 21, 2014
PR News Wire – October 18, 2013
Genetic Engineering and Biotech News – August 15, 2013
MedCity News – August 15, 2013
Genalyte, Inc. Completes $12 Million Series B Financing to Commercialize Its Maverickac Next-Generation Multiplexing Platform
PR News Wire – March 30, 2102
Biz Journal – March 30, 2012
Laser Focus World – January 31, 2012
Phys – January 25, 2012